Ad5-boosted COVID-19 vaccine reduces symptomatic BA.5 infection via cross-neutralizing antibodies and NK cell immunity.
Ad5 增强型 COVID-19 疫苗通过交叉中和抗体和 NK 细胞免疫减少有症状的 BA.5 感染。
期刊:BMC Medicine
影响因子:8.3
doi:10.1186/s12916-025-04505-0
Cui Tingting, Liu Siyi, Wang Tingting, Liu Yarui, Liang Xinyue, Chen Faming, Huang Mingzhu, Su Xiaoling, Song Tao, Su Jie, Deng Shidong, Zhao Jincun, Yu Fulong, Wang Zhongfang